Trial intelligence / Profile preview

Nicorandil vs Nitroglycerin in Slow Coronary Flow

NCT02254252Phase 4Completed

Sponsor
Mashhad University of Medical Sciences
Start
Mar 2012
Primary completion
Mar 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of nicorandil in Coronary Slow Flow Phenomenon (CSFP), stable angina pectoris, sponsored by Mashhad University of Medical Sciences. Started Mar 2012; status: completed.

02

Drugs

nicorandil
03

Conditions

Coronary Slow Flow Phenomenon (CSFP)stable angina pectoris

Beyond the preview

Go deeper on NCT02254252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02254252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call